Healthcare Finance News August 21, 2024
Walgreens says it has reached more than five million patients to potentially recruit into clinical trials since its launch in 2022.
Walgreens is partnering with the Biomedical Advanced Research and Development Authority (BARDA) – part of the Administration for Strategic Preparedness and Response in the Department of Health and Human Services – to increase innovation in decentralized clinical trials as part of the Decentralized Clinical Operations for Healthcare and Research program.
The D-COHRe program is designed to strengthen decentralized clinical research capabilities, thereby supporting development of U.S. Food and Drug Administration-regulated products, enhancing clinical innovation to execute more efficient and relevant clinical research, and evaluating other medical countermeasures in real-world environments that may be used in a public health emergency.
...Today's Sponsors
Today's Sponsor